Sutro Biopharma (STRO) PT Lowered to $20 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts STRO Hot Sheet
Price: $9.10 -0.44%
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 7
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 7
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein lowered the price target on Sutro Biopharma (NASDAQ: STRO) to $20.00 (from $30.00) while maintaining a Buy rating.
You May Also Be Interested In
- Acumen Pharmaceuticals, Inc. (ABOS) PT Lowered to $1 at BTIG
- Banco Bilbao Vizcaya Argentaria SA (BBVA:SM) (BBVA) PT Lowered to EUR22.70 at UBS
- Abbvie (ABBV) PT Raised to $340 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
